Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease

被引:33
作者
El Marabti, Ettaib [1 ]
Abdel-Wahab, Omar [2 ,3 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Clin Transplant Res Div, Seattle, WA 98109 USA
[2] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
PRE-MESSENGER-RNA; SPINAL MUSCULAR-ATROPHY; SURVIVAL MOTOR-NEURON; RESTORES DYSTROPHIN EXPRESSION; ANTISENSE OLIGONUCLEOTIDES; SMN2; GENE; DEVELOPMENTAL DISORDER; MINOR SPLICEOSOME; INTRON MUTATION; SR PROTEIN;
D O I
10.1016/j.molmed.2021.04.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RNA splicing is the enzymatic process by which non-protein coding sequences are removed from RNA to produce mature protein-coding mRNA. Splicing is thereby a major mediator of proteome diversity as well as a dynamic regulator of gene expression. Genetic alterations disrupting splicing of individual genes or altering the function of splicing factors contribute to a wide range of human genetic diseases as well as cancer. These observations have resulted in the development of therapies based on oligonucleotides that bind to RNA sequences and modulate splicing for therapeutic benefit. In parallel, small molecules that bind to splicing factors to alter their function or modify RNA processing of individual transcripts are being pursued for monogenic disorders as well as for cancer.
引用
收藏
页码:643 / 659
页数:17
相关论文
共 169 条
  • [1] Splicing mutation associated with Rett syndrome and an experimental approach for genetic diagnosis
    Abuhatzira, L
    Makedonski, K
    Galil, YP
    Gak, E
    Ben Zeev, B
    Razin, A
    Shemer, R
    [J]. HUMAN GENETICS, 2005, 118 (01) : 91 - 98
  • [2] Targeting splicing abnormalities in cancer
    Agrawal, Anant A.
    Yu, Lihua
    Smith, Peter G.
    Buonamici, Silvia
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2018, 48 : 67 - 74
  • [3] Gene structure and mutant alleles of PCDH15: nonsyndromic deafness DFNB23 and type 1 Usher syndrome
    Ahmed, Zubair M.
    Riazuddin, Saima
    Aye, Sandar
    Ali, Rana A.
    Venselaar, Hanka
    Anwar, Saima
    Belyantseva, Polina P.
    Qasim, Muhammad
    Riazuddin, Sheikh
    Friedman, Thomas B.
    [J]. HUMAN GENETICS, 2008, 124 (03) : 215 - 223
  • [4] Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
    Alter, J
    Lou, F
    Rabinowitz, A
    Yin, HF
    Rosenfeld, J
    Wilton, SD
    Partridge, TA
    Lu, QL
    [J]. NATURE MEDICINE, 2006, 12 (02) : 175 - 177
  • [5] Discovery of a CNS penetrant small molecule SMN2 splicing modulator with improved tolerability for spinal muscular atrophy
    Ando, Shiori
    Suzuki, Shunya
    Okubo, Shoichi
    Ohuchi, Kazuki
    Takahashi, Kei
    Nakamura, Shinsuke
    Shimazawa, Masamitsu
    Fuji, Koji
    Hara, Hideaki
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [6] PRESERVATION OF THE C-TERMINUS OF DYSTROPHIN MOLECULE IN THE SKELETAL-MUSCLE FROM BECKER MUSCULAR-DYSTROPHY
    ARAHATA, K
    BEGGS, AH
    HONDA, H
    ITO, S
    ISHIURA, S
    TSUKAHARA, T
    ISHIGURO, T
    EGUCHI, C
    ORIMO, S
    ARIKAWA, E
    KAIDO, M
    NONAKA, I
    SUGITA, H
    KUNKEL, LM
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 101 (02) : 148 - 156
  • [7] Defective minor spliceosome mRNA processing results in isolated familial growth hormone deficiency
    Argente, Jesus
    Flores, Raquel
    Gutierrez-Arumi, Armand
    Verma, Bhupendra
    Martos-Moreno, Gabriel A.
    Cusco, Ivon
    Oghabian, Ali
    Chowen, Julie A.
    Frilander, Mikko J.
    Perez-Jurado, Luis A. '
    [J]. EMBO MOLECULAR MEDICINE, 2014, 6 (03) : 299 - 306
  • [8] Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene
    Aznarez, I
    Chan, EM
    Zielenski, J
    Blencowe, BJ
    Tsui, LC
    [J]. HUMAN MOLECULAR GENETICS, 2003, 12 (16) : 2031 - 2040
  • [9] Identification and characterization of Gemin7, a novel component of the survival of motor neuron complex
    Baccon, J
    Pellizzoni, L
    Rappsilber, J
    Mann, M
    Dreyfuss, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) : 31957 - 31962
  • [10] Donor splice-site mutations in WT1 are responsible for Frasier syndrome
    Barbaux, S
    Niaudet, P
    Gubler, MC
    Grunfeld, JP
    Jaubert, F
    Kuttenn, F
    Fekete, CN
    SouleyreauTherville, N
    Thibaud, E
    Fellous, M
    McElreavey, K
    [J]. NATURE GENETICS, 1997, 17 (04) : 467 - 470